Atlas FDA

Cardiac Resynchronization Therapy Defibrillator

FDA premarket approval P060027/S099 · decided 2019-03-05

Approval details

PMA number
P060027
Supplement
S099
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Cardiac Resynchronization Therapy Defibrillator
Generic name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Applicant
MicroPort CRM USA, Inc.
Date received
2019-02-05
Decision date
2019-03-05
Days to decision
28 days
Decision code
OK30
Product code
NIK
Advisory committee
Cardiovascular
Expedited review
No
Location
Arlington, TN
Statement
Addition of a pre-conditioning step prior to the Electrical Wafer Sorting test.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.